Strides Pharma gains after arm receives US-FDA nod for Pregabalin capsule
The Pregabalin capsule is used in the treatment of fibromyalgia, is a chronic health condition that causes pain and tenderness throughout the body. Strides Pharma Science share price gained a percent in the opening trade on January 29 after the company said it received the approval of the United States Food and Drug Administration (USFDA) approval to sell a generic drug for nerve pain.
The company's step‐down wholly owned subsidiary Strides Pharma Global Pte Limited, Singapore has received the nod for Pregabalin capsules, 25 mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg from the US drug regulator.
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Lyrica capsules of Upjohn US. The capsule is used in the treatment of fibromyalgia.
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
